# EV Biotech

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ev-biotech-b-v

- Industry: Biotechnology
- Headquarters: Netherlands
- Website: www.evbio.tech
- Total disclosed funding: $4.8M
- Latest round: Seed (Mar 18, 2023)
- Investors on record: 7

## About

Based in Groningen, Netherlands, and founded in 2018, EV Biotech B.V. operates as a microbial cell factory (MCF) strain development company that provides solutions for the development of microbial-derived products. In March 2023, EV Biotech B.V., raised EUR 4.5 million in seed funding led by Future Food Fund, with participation from other new investors Blue Horizon, Carduso Capital, NOM, RUG Ventures, Triade Investment, and Voyageurs. As of 2023, the company partners with companies like Triade, BeStart, Live Cooperative, and many more.

The company offers artificial intelligence-based technology solutions used for the development of sustainable compound production. The company integrates data-driven predictive algorithms with strain design and development to create microbial chassis to produce vanillin, spider Silk, terpenes, and PHAs.

The company plans to use the March 2023 funding to advance its current technology, enhance its offerings by implementing client feedback, develop in-house microorganisms to serve several markets, and pilot its in-house plug-and-play systems to create a microbial chassis that produces different kinds of bioplastics.

## Funding rounds

- Seed, Mar 18, 2023, $4.8M — NOM, Future Food Fund, Blue Horizon, VOYAGERS, RUG Ventures, Carduso Capital, Triade Investment

## Investors

- NOM (https://capitalatlas.ai/funds/nom) — Seed
- Future Food Fund — Seed
- Blue Horizon (https://capitalatlas.ai/funds/blue-horizon) — Seed
- VOYAGERS (https://capitalatlas.ai/funds/voyagers) — Seed
- RUG Ventures (https://capitalatlas.ai/funds/rug-ventures) — Seed
- Carduso Capital (https://capitalatlas.ai/funds/carduso-capital) — Seed
- Triade Investment — Seed